In conclusion, through the protective effect of the pulmonary microvascular barrier, TXL inhibits pulmonary inflammation and systemic inflammation, thus enhancing the effect of Ato on COPD combined with AS. Here, TXNL1 is linked to chronic obstructive pulmonary disease.